Sinemet: Restoring Motor Control in Parkinson's Disease
| Product dosage: 110mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.04 | $62.40 $62.40 (0%) | 🛒 Add to cart |
| 90 | $0.96 | $93.60 $86.55 (8%) | 🛒 Add to cart |
| 120 | $0.92 | $124.80 $110.71 (11%) | 🛒 Add to cart |
| 180 | $0.88 | $187.20 $158.01 (16%) | 🛒 Add to cart |
| 270 | $0.86 | $280.80 $231.48 (18%) | 🛒 Add to cart |
| 360 | $0.84
Best per pill | $374.40 $300.93 (20%) | 🛒 Add to cart |
| Product dosage: 125mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.54 | $46.30 (0%) | 🛒 Add to cart |
| 60 | $1.31 | $92.59 $78.50 (15%) | 🛒 Add to cart |
| 90 | $1.22 | $138.89 $109.70 (21%) | 🛒 Add to cart |
| 120 | $1.17 | $185.19 $140.90 (24%) | 🛒 Add to cart |
| 180 | $1.14 | $277.78 $204.31 (26%) | 🛒 Add to cart |
| 270 | $1.11 | $416.67 $298.91 (28%) | 🛒 Add to cart |
| 360 | $1.10
Best per pill | $555.56 $394.53 (29%) | 🛒 Add to cart |
| Product dosage: 275mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.45 | $73.47 (0%) | 🛒 Add to cart |
| 60 | $2.06 | $146.94 $123.79 (16%) | 🛒 Add to cart |
| 90 | $1.93 | $220.41 $174.11 (21%) | 🛒 Add to cart |
| 120 | $1.87 | $293.88 $224.44 (24%) | 🛒 Add to cart |
| 180 | $1.80 | $440.82 $324.07 (26%) | 🛒 Add to cart |
| 270 | $1.76 | $661.23 $476.05 (28%) | 🛒 Add to cart |
| 360 | $1.74
Best per pill | $881.64 $627.01 (29%) | 🛒 Add to cart |
Synonyms
| |||
Sinemet is a cornerstone prescription medication specifically formulated for the management of Parkinson’s disease and parkinsonism resulting from carbon monoxide or manganese intoxication. It combines two active ingredients, carbidopa and levodopa, in a single tablet to effectively address the core motor symptoms of these conditions. This combination therapy is designed to replenish depleted dopamine levels in the brain, the fundamental neurochemical deficit in Parkinson’s. By doing so, it directly targets tremors, rigidity, bradykinesia, and postural instability, offering patients a significant restoration of functional mobility and quality of life. Its efficacy and established history make it a first-line treatment option in neurological therapeutic regimens.
Features
- Dual-active formulation containing carbidopa and levodopa.
- Available in immediate-release (IR) and controlled-release (CR) tablets to suit individual patient needs.
- Standardized dosage strengths (e.g., 10mg/100mg, 25mg/100mg, 25mg/250mg) for precise titration.
- Carbidopa component inhibits peripheral decarboxylation of levodopa, allowing more levodopa to cross the blood-brain barrier.
- Manufactured under strict pharmaceutical quality control standards.
Benefits
- Significant Reduction in Motor Symptoms: Effectively alleviates resting tremor, muscle stiffness (rigidity), and slowness of movement (bradykinesia).
- Improved Functional Independence: Enhances the ability to perform daily activities such as walking, dressing, and eating, promoting greater autonomy.
- Smoother Therapeutic Effect: The inclusion of carbidopa reduces peripheral side effects like nausea and allows for a lower overall dose of levodopa to achieve the desired central effect.
- Established Efficacy and Safety Profile: Decades of clinical use and research support its role as a reliable and well-understood therapy.
- Dosage Flexibility: Multiple strengths and formulations (IR/CR) allow neurologists to tailor treatment to the specific stage and symptom pattern of the patient’s disease.
Common use
Sinemet is primarily indicated for the treatment of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide or manganese intoxication. It is not indicated for drug-induced parkinsonism or Huntington’s chorea. Its use is targeted at patients experiencing motor symptoms that are significant enough to interfere with work, social functioning, or activities of daily living.
Dosage and direction
Dosage is highly individualized and must be titrated carefully by a neurologist based on therapeutic response and emergence of side effects. Treatment is typically initiated with a low dose, such as one tablet of Sinemet 25/100 (containing 25 mg carbidopa and 100 mg levodopa) taken three times daily. The dose may be increased by one tablet every day or every other day until a maximum therapeutic response is achieved. The usual maintenance dose is 3 to 8 tablets of Sinemet 25/100 daily, divided into 4 to 8 doses. The interval between doses usually ranges from 4 to 8 hours while awake. Controlled-release (CR) tablets may be used to provide a longer duration of action, especially for managing nighttime symptoms or “wearing-off” effects, and are typically administered at longer intervals. Tablets should be swallowed whole and not crushed or chewed. It is often advised to take Sinemet with food to minimize nausea, especially upon initiation, though high-protein meals can interfere with absorption.
Precautions
- Long-Term Use Effects: Long-term therapy may be associated with motor complications, including end-of-dose “wearing off,” sudden “on-off” fluctuations, and dyskinesias (involuntary movements). These require careful medical management.
- Cardiovascular Effects: Orthostatic hypotension (a drop in blood pressure upon standing) can occur. Monitoring is advised, especially at initiation and after dosage increases.
- Mental Status Changes: Patients may experience confusion, hallucinations, paranoia, or depression. Caution is required in patients with a history of psychosis or severe psychiatric disorders.
- Melanoma Risk: Epidemiological studies have shown that patients with Parkinson’s disease have a higher risk of melanoma. It is not clear if this is due to the disease or levodopa therapy. Regular dermatological screening is recommended.
- Sudden Sleep Onset: Drowsiness and episodes of suddenly falling asleep without warning (“sleep attacks”) have been reported. Patients should be cautioned about operating machinery or driving until they know how the drug affects them.
- Impulse Control Disorders: Use has been associated with compulsive behaviors such as gambling, hypersexuality, binge eating, and compulsive shopping. Patients and caregivers should be monitored for new or increased impulsive behaviors.
- Withdrawal: Abrupt withdrawal or rapid dose reduction may lead to a life-threatening symptom complex resembling neuroleptic malignant syndrome (NMS), characterized by fever, muscular rigidity, altered consciousness, and autonomic instability.
Contraindications
Sinemet is contraindicated in patients with:
- Known hypersensitivity to any components of the medication.
- Narrow-angle glaucoma.
- Patients who have taken a nonselective monoamine oxidase (MAO) inhibitor within the past 14 days, due to the risk of hypertensive crisis.
- History of melanoma or undiagnosed skin lesions.
Possible side effects
Side effects are often dose-related and may diminish with time or dosage adjustment.
- Very Common (>10%): Dyskinesias (involuntary movements), nausea, dizziness, orthostatic hypotension.
- Common (1-10%): Vomiting, anorexia, cardiac arrhythmias, hypotension, syncope, depression with suicidal tendencies, dementia, anxiety, nightmares, insomnia, hallucinations, confusion, agitation, headache, dizziness, numbness, increased libido, bruxism, dysphagia, diarrhea, constipation, dry mouth, dark discoloration of saliva, urine, or sweat, elevated liver enzymes, rash, alopecia.
- Uncommon (<1%): Gastrointestinal bleeding, duodenal ulcer, hypertension, phlebitis, leukopenia, agranulocytosis, hemolytic anemia, positive Coombs test.
Drug interaction
Concomitant use with the following drugs requires extreme caution and likely dosage adjustment:
- MAO Inhibitors: Concomitant use with nonselective MAOIs is contraindicated. Dose-related hypertension may occur with selective MAO-B inhibitors (e.g., selegiline, rasagiline).
- Dopamine D2 Receptor Antagonists: Antipsychotics (e.g., phenothiazines, butyrophenones, risperidone) and metoclopramide may diminish the effectiveness of Sinemet.
- Antihypertensives: May potentiate the hypotensive effects of antihypertensive drugs.
- Anticholinergics: May enhance the efficacy of levodopa but also increase the risk of adverse effects.
- Sympathomimetics: May increase the risk of arrhythmias, as levodopa is a precursor to catecholamines like norepinephrine.
- Ferrous Sulfate (Iron): May reduce the bioavailability of levodopa. Doses should be separated.
- Protein-Rich Diets: Large meals high in protein can compete with levodopa for intestinal absorption and transport across the blood-brain barrier, reducing its efficacy.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not double the next dose to make up for a missed one, as this increases the risk of side effects. Maintain the regular dosing schedule. Consult a physician if multiple doses are missed.
Overdose
Overdose is primarily characterized by exaggerated therapeutic and adverse effects. Signs and symptoms include severe dyskinesias, agitation, confusion, hallucinations, hypotension, arrhythmias, nausea, and vomiting. Management is symptomatic and supportive. There is no specific antidote. ECG monitoring should be instituted, and the patient’s airway should be protected. Gastric lavage may be considered with appropriate airway protection. The efficacy of hemodialysis or peritoneal dialysis is not well established for this combination drug.
Storage
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Protect from light and moisture. Keep in the original container, tightly closed. Keep all medications out of the reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or altering any treatment regimen. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- Clinical Neurologist, 20 years experience: “Sinemet remains the gold standard for symptomatic control in Parkinson’s disease. While we now have many adjunctive therapies, the significant and rapid improvement in motor function it provides is unparalleled. My focus is always on careful, slow titration to maximize benefit and minimize long-term motor complications.”
- Parkinson’s Patient, 7 years on therapy: “It gave me my life back. The stiffness and slowness that made everything a chore improved dramatically within the first week. I have had to work with my doctor to manage some dyskinesias over the years, but the trade-off for being able to function is worth it.”
- Movement Disorder Specialist: “The introduction of carbidopa/levodopa was a revolution in neurology. It is a powerful tool, but it requires a sophisticated approach. We use it not just to treat symptoms, but to strategically manage the disease course, often combining it with other agents to smooth out the response and delay complications.”